The protein transition is in full swing - and entrepreneurs in the meat sector can no longer stay away from it either. Dutch scale-up The Protein Brewery recently raised €30 million in growth capital to roll out its fungi-based protein ingredient Fermotein® internationally. For producers of meat products, snacks and sports nutrition, this new ingredient could be both an opportunity and a potential threat - depending on how one responds to the changing market and consumer demand.
Fermotein® is a fungus-based protein and fibre ingredient produced via fermentation with a patented, non-genetically modified fungus. The product is tasteless and odourless, and suitable for applications in, among others:
The protein contains a complete amino acid profile and high fibre, and comes from a sustainable production process that requires less water, land and energy than traditional animal or plant proteins.
At a time when consumers are becoming increasingly critical of genetic modification (GMO), The Protein Brewery is firmly establishing itself as a producer of non-GMO ingredients. Fermotein® is produced from a naturally selected fungal strain, and according to the company, both the production process and the final product contain no genetically modified organisms.
This is an important distinction from other alternative proteins produced through precision fermentation, which often does involve genetically modified micro-organisms. For consumers who value natural food without biotechnological interventions, Fermotein® may therefore be a more attractive alternative - if properly communicated.
For the traditional meat sector, such innovations are not direct substitutes for meat, but they do represent competition in certain applications:
Fermotein® has already reached an important milestone in the United States, where it obtained GRAS (Generally Recognised As Safe) status, meaning the ingredient is recognised as safe for consumption. Also in Singapore, Fermotein® has been officially approved for the market since 2024, which has already given the company an international foothold. In Europe and the UK, the approval processes are still in the final stages under strict Novel Foods regulations. Although the commercial application of Fermotein® within the EU is currently still limited, these barriers are expected to disappear in the coming years, paving the way for wider deployment here too.
CEO Thijs Bosch calls the investment a stepping stone: “With Fermotein®, we are redefining the way food is made - nutritious, sustainable, scalable and cost-efficient. We offer an alternative to animal and plant proteins that can be incorporated into countless applications without compromising on quality.”
The investment was led by Invest-NL and the Brabant Development Company (BOM), with support from existing shareholders such as Novo Holdings and Unovis.
For entrepreneurs in the meat sector, the emergence of fungi-proteins such as Fermotein® especially offers opportunities for innovation - provided it is communicated clearly and honestly to consumers. The “non-GMO” nature of Fermotein® makes it suitable for critical audiences, provided you explain the natural origin and fermentation process well.
In short: alternative proteins are not just for vegans. They can also be a building block for meat companies that want to move with the times - without losing their core identity.
Sources:
https://ioplus.nl/en/posts/startup-raises-30-million-for-global-rollout-of-fungal-proteins
